XML 126 R105.htm IDEA: XBRL DOCUMENT v3.22.4
Segment and Geographic Information - Schedule of Customer Concentration by Collaboration Partners and Distribution Entity (Detail) - Customer Concentration Risk [Member]
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Percentage of Revenue [Member] | Falikang—Related party      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 51.00% 15.00% 0.00%
Percentage of Revenue [Member] | Astellas-Related party [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 31.00% 57.00% 21.00%
Percentage of Revenue [Member] | AstraZeneca [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 9.00% 20.00% 37.00%
Percentage of Accounts Receivable [Member] | Falikang—Related party      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 65.00% 0.00%  
Percentage of Accounts Receivable [Member] | Astellas-Related party [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 9.00% 63.00%  
Percentage of Accounts Receivable [Member] | AstraZeneca [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 16.00% 34.00%